Price To Earnings Ratio 8.13 | Sector PE 37.41 |
PB Ratio 2.02 | Sector PB 6.48 |
EPS 105.33 | Dividend Yield 0.75 |
Today's Volume 255.176 K | 5 Day Avg. Volume 295.832 K |
PEG Ratio 0.23 | Market Cap. ₹ 15,440.00 Cr. |
Natco Pharma Limited is a vertically integrated R&D pharmaceutical company based in India. The company's field of activity is the pharmaceutical business, which includes research and development, production and sale of bulk drugs and ready-made medical preparations. The company produces ready-to-use dosage forms (FDFs), which it sells in India, the US and the rest of the world, and also produces active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic splicing technologies, production of potent APIs and peptides. The company operates in two segments: Pharmaceuticals and Agricultural Chemicals. In the pharmaceutical industry, the Company channels its sales through FDFs and APIs. The agrochemicals segment focuses on specialty products, including pest control.